Used in pharmaceutical research as a potent and selective inhibitor targeting specific kinase pathways involved in inflammatory and autoimmune diseases. Shows promise in modulating immune responses by inhibiting key signaling proteins, making it a candidate for development in treatments for conditions such as rheumatoid arthritis and psoriasis. Its structure allows for high binding affinity and improved metabolic stability, which supports oral bioavailability in preclinical studies. Currently investigated in early-stage drug discovery programs for its therapeutic potential and safety profile.